Popular Articles

Infrastructure experience must for PPP project bids
Petroleum and natural gas companies without any experience in executing infrastructure projects will no longer be able to bid for projects under the public private partnership (PPP) model.

Govt withdraws four directors from Satyam board
The Union government has withdrawn four of the six directors appointed by it on the board of Satyam Computer Services Limited. The government has taken this decision following the permission granted by the Company Law Board (CLB) to this effect.

News of the day

CP-CD: issues fall as MFs stay away
Issuances of short-term money market instruments fell today because mutual funds — the major investors for such papers —were not keen on investing due to low rates, dealers said.
Small Business

Nektar, Astrazenca sign licensing agreement

Nektar Therapeutics today said it has entered into a licensing agreement with multinational drug firm Astrazenca for developing two drugs for the treatment of constipation and pain, which could fetch it up to $375 million. Sensex ends up 35pts Under the agreement, Nektar will receive an upfront payment of $125 million for both compounds and it can get a payment of up to $235 million on achieving certain regulatory milestones. The company may get payments of up to $375 million if the product achieves considerable commercial success. "Nektar will also be eligible to receive significant double-digit royalty payments on sales of NKTR-118 worldwide," the company said. NKTR-118, is being developed for the treatment of constipation using opium-based pain relieving products and NKTR-119 for treatment of pain without constipation. The agreement is, however, subject to review by the US authorities. Nektar is headquartered in San Carlos, California and has a research and development facility in India.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):